Ongericimab (anti-PCSK9) is a humanized anti-PCSK9 monoclonal antibody. Ongericimab (anti-PCSK9) has lipid-lowering efficacy. Ongericimab (anti-PCSK9) can be used in research of hypercholesteremia and hyperlipidemia.
Specification: ExactAb™, Validated, Carrier Free, Low Endotoxin, Azide Free, Recombinant, ≥95%(SDS-PAGE&SEC), Lot by Lot
Related Documents: https://ald-pub-files.oss-cn-shanghai.aliyuncs.com/aladdinsci/pdp/sds/1/AB182886-SCI_8971eda8c50a66d62a05160ca9faceff.pdf
- UPC:
- 51321604
- Condition:
- New
- Availability:
- 4-8 weeks
- Weight:
- 0.07 Ounces
- HazmatClass:
- No
- WeightUOM:
- LB
- MPN:
- Ab182886-10mg
- CAS:
- 2145096-91-7
- Product Size:
- 10mg